ER/PR Positive Breast Cancer

Oncology

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target ER/PR Positive Breast Cancer?

There are 1 clinical trial targeting ER/PR Positive Breast Cancer tracked by BioSniper.

What is the prevalence of ER/PR Positive Breast Cancer?

The estimated prevalence of ER/PR Positive Breast Cancer is approximately 287.0 per 100,000 population.

Deep-dive into ER/PR Positive Breast Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    ER/PR Positive Breast Cancer — Drugs in Development & Clinical Trials | BioSniper